Coen A C Ottenheijm Selected Research

Contractile Proteins

1/2018	Positive End-Expiratory Pressure Ventilation Induces Longitudinal Atrophy in Diaphragm Fibers.
6/2013	Troponin activator augments muscle force in nemaline myopathy patients with nebulin mutations.
1/2008	Diaphragm adaptations in patients with COPD.
6/2007	Diaphragm muscle fiber dysfunction in chronic obstructive pulmonary disease: toward a pathophysiological concept.
11/2006	Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease.
1/2006	Hypoxia-induced skeletal muscle fiber dysfunction: role for reactive nitrogen species.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Coen A C Ottenheijm Research Topics

Disease

16	Muscle Weakness 01/2021 - 07/2009
15	Nemaline Myopathies (Nemaline Myopathy) 01/2021 - 07/2009
9	Muscular Diseases (Myopathy) 08/2021 - 05/2011
7	Atrophy 01/2022 - 02/2011
5	Critical Illness (Critically Ill) 10/2021 - 04/2014
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2008 - 07/2005
2	Body Weight (Weight, Body) 01/2022 - 01/2019
2	Disease Progression 01/2020 - 04/2014
2	Neoplasms (Cancer) 05/2015 - 12/2011
2	Heart Failure 06/2008 - 07/2007
1	Cardiomegaly (Heart Hypertrophy) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Lung Injury 01/2022
1	Glucose Intolerance 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Hypertrophy 01/2020
1	Fibrosis (Cirrhosis) 01/2016
1	Facioscapulohumeral Muscular Dystrophy 10/2013
1	Neuromuscular Diseases (Neuromuscular Disease) 06/2013
1	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 04/2012
1	Hypoxia (Hypoxemia) 01/2006
1	Hyperoxia 01/2006

Drug/Important Bio-Agent (IBA)

13	nebulinIBA 01/2020 - 07/2009
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2005
6	Contractile ProteinsIBA 01/2018 - 01/2006
5	ConnectinIBA 01/2020 - 03/2006
5	UbiquitinIBA 05/2015 - 07/2005
4	TroponinIBA 08/2021 - 06/2013
4	Myosins (Myosin)IBA 11/2015 - 11/2006
4	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2015 - 11/2006
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022
1	CytokinesIBA 01/2022
1	CK-2017357IBA 01/2021
1	Nonsense Codon (Nonsense Mutation)IBA 01/2020
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2019
1	CollagenIBA 01/2016
1	CalciumIBA 06/2013
1	tenascin XIBA 04/2012
1	Glycoproteins (Glycoprotein)IBA 04/2012
1	TropomyosinIBA 05/2011
1	Proteasome InhibitorsIBA 06/2007
1	Messenger RNA (mRNA)IBA 11/2006
1	Ligases (Synthetase)IBA 11/2006
1	Caspase 3 (Caspase-3)IBA 11/2006
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2006
1	Reactive Nitrogen SpeciesIBA 01/2006
1	3-nitrotyrosineIBA 01/2006
1	Arginine (L-Arginine)FDA Link 01/2006
1	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 01/2006
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 07/2005

Therapy/Procedure

5	Mechanical Ventilators (Ventilator) 10/2021 - 05/2015
5	Therapeutics 01/2021 - 05/2011
4	Artificial Respiration (Mechanical Ventilation) 01/2022 - 05/2015
3	Length of Stay 01/2018 - 05/2015
1	Ventilator Weaning 10/2021
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2018
1	Thoracotomy 12/2011